市場調査レポート
商品コード
1411534

CRISPR遺伝子編集市場:製品、サービス、技術、用途、エンドユーザー別-2024-2030年の世界予測

CRISPR Gene Editing Market by Product (Enzymes, Kits, Libraries), Services (Cell Line Engineering, gRNA design, Screening), Technology, Application, End User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
CRISPR遺伝子編集市場:製品、サービス、技術、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CRISPR遺伝子編集市場規模は2023年に35億7,000万米ドルと推計され、2024年には41億8,000万米ドルに達し、CAGR 11.65%で2030年には77億2,000万米ドルに達すると予測されます。

CRISPR遺伝子編集の世界市場

主な市場の統計
基準年[2023] 35億7,000万米ドル
予測年[2024] 41億8,000万米ドル
予測年 [2030] 77億2,000万米ドル
CAGR(%) 11.65%
CRISPR遺伝子編集 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはCRISPR遺伝子編集市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、CRISPR遺伝子編集市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-CRISPR遺伝子編集市場の市場規模および予測は?

2-CRISPR遺伝子編集市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-CRISPR遺伝子編集市場における技術動向と規制の枠組みは?

4-CRISPR遺伝子編集市場における主要ベンダーの市場シェアは?

5-CRISPR遺伝子編集市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患と遺伝性疾患の増加
      • 食料安全保障を改善するためのCRISPR遺伝子編集の採用
      • 主要企業によるCRISPR調査と投資を推進する政府の取り組み
    • 抑制要因
      • CRISPR療法の高額な費用
    • 機会
      • 個別化医療とがん治療のためのCRISPR編集ツールの採用
      • 宇宙旅行を推進するためのCRISPRの利用
    • 課題
      • ゲノム編集に関する厳しい規制と倫理的懸念
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 CRISPR遺伝子編集市場:製品別

  • 酵素
  • キット
  • 図書館

第7章 CRISPR遺伝子編集市場:サービス別

  • 細胞株工学
  • gRNAの設計
  • ふるい分け

第8章 CRISPR遺伝子編集市場:技術別

  • クリスパー
  • タレン
  • ZFN

第9章 CRISPR遺伝子編集市場:用途別

  • 細胞株工学
  • 診断
  • 創薬
  • 遺伝子改変細胞療法
  • 遺伝子工学

第10章 CRISPR遺伝子編集市場:エンドユーザー別

  • 学術機関および政府機関
  • バイオテクノロジーおよび製薬会社
  • 受託調査機関

第11章 南北アメリカのCRISPR遺伝子編集市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のCRISPR遺伝子編集市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのCRISPR遺伝子編集市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AstraZeneca plc
    • Beam Therapeutics Inc.
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories, Inc.
    • Biorad
    • Calyxt, Inc.
    • Caribou Biosciences, Inc.
    • CRISPR Therapeutics AG
    • Danaher Corporation
    • Editas Medicine, Inc.
    • F. Hoffmann-La Roche AG
    • Hera Biolabs
    • Horizon Discovery Group Plc
    • Inscripta, Inc.
    • Integrated Dna Technologies, Inc.
    • Intellia Therapeutics, Inc.
    • Lonza Group
    • Mammoth Biosciences
    • Merck KGaA
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CRISPR GENE EDITING MARKET DYNAMICS
  • FIGURE 7. CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 10. CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. CRISPR GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. CRISPR GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR GENE EDITING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CRISPR GENE EDITING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CRISPR GENE EDITING MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 10. CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CRISPR GENE EDITING MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CRISPR GENE EDITING MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. CRISPR GENE EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CRISPR GENE EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CRISPR GENE EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CRISPR GENE EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CRISPR GENE EDITING MARKET SIZE, BY GENE-MODIFIED CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. CRISPR GENE EDITING MARKET SIZE, BY ACADEMICS & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CRISPR GENE EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CRISPR GENE EDITING MARKET LICENSE & PRICING
目次
Product Code: MRR-5C6F41F5AFAA

[181 Pages Report] The CRISPR Gene Editing Market size was estimated at USD 3.57 billion in 2023 and expected to reach USD 4.18 billion in 2024, at a CAGR 11.65% to reach USD 7.72 billion by 2030.

Global CRISPR Gene Editing Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.57 billion
Estimated Year [2024] USD 4.18 billion
Forecast Year [2030] USD 7.72 billion
CAGR (%) 11.65%
CRISPR Gene Editing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CRISPR Gene Editing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CRISPR Gene Editing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Beam Therapeutics Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Biorad, Calyxt, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, Hera Biolabs, Horizon Discovery Group Plc, Inscripta, Inc., Integrated Dna Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group, Mammoth Biosciences, Merck KGaA, Qiagen NV, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Enzymes
    • Kits
    • Libraries
  • Services
    • Cell Line Engineering
    • gRNA design
    • Screening
  • Technology
    • CRISPR
    • TALEN
    • ZFN
  • Application
    • Cell Line Engineering
    • Diagnostics
    • Drug Discovery
    • Gene-modified Cell Therapy
    • Genetic Engineering
  • End User
    • Academics & Government Institutes
    • Biotechnology & Pharma Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the CRISPR Gene Editing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CRISPR Gene Editing Market?

3. What are the technology trends and regulatory frameworks in the CRISPR Gene Editing Market?

4. What is the market share of the leading vendors in the CRISPR Gene Editing Market?

5. Which modes and strategic moves are suitable for entering the CRISPR Gene Editing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. CRISPR Gene Editing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of chronic diseases and genetic disorders
      • 5.1.1.2. Adoption of CRISPR gene editing to improve food security
      • 5.1.1.3. Government initiatives to propel CRISPR research and investment by major players
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRISPR therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of CRISPR editing tools for personalized medicine and cancer therapeutics
      • 5.1.3.2. Utilization of CRISPR to propel space travel
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations concerning genome editing and ethical concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. CRISPR Gene Editing Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymes
  • 6.3. Kits
  • 6.4. Libraries

7. CRISPR Gene Editing Market, by Services

  • 7.1. Introduction
  • 7.2. Cell Line Engineering
  • 7.3. gRNA design
  • 7.4. Screening

8. CRISPR Gene Editing Market, by Technology

  • 8.1. Introduction
  • 8.2. CRISPR
  • 8.3. TALEN
  • 8.4. ZFN

9. CRISPR Gene Editing Market, by Application

  • 9.1. Introduction
  • 9.2. Cell Line Engineering
  • 9.3. Diagnostics
  • 9.4. Drug Discovery
  • 9.5. Gene-modified Cell Therapy
  • 9.6. Genetic Engineering

10. CRISPR Gene Editing Market, by End User

  • 10.1. Introduction
  • 10.2. Academics & Government Institutes
  • 10.3. Biotechnology & Pharma Companies
  • 10.4. Contract Research Organizations

11. Americas CRISPR Gene Editing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific CRISPR Gene Editing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa CRISPR Gene Editing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. AstraZeneca plc
    • 15.1.2. Beam Therapeutics Inc.
    • 15.1.3. Beckman Coulter, Inc.
    • 15.1.4. Bio-Rad Laboratories, Inc.
    • 15.1.5. Biorad
    • 15.1.6. Calyxt, Inc.
    • 15.1.7. Caribou Biosciences, Inc.
    • 15.1.8. CRISPR Therapeutics AG
    • 15.1.9. Danaher Corporation
    • 15.1.10. Editas Medicine, Inc.
    • 15.1.11. F. Hoffmann-La Roche AG
    • 15.1.12. Hera Biolabs
    • 15.1.13. Horizon Discovery Group Plc
    • 15.1.14. Inscripta, Inc.
    • 15.1.15. Integrated Dna Technologies, Inc.
    • 15.1.16. Intellia Therapeutics, Inc.
    • 15.1.17. Lonza Group
    • 15.1.18. Mammoth Biosciences
    • 15.1.19. Merck KGaA
    • 15.1.20. Qiagen NV
    • 15.1.21. Thermo Fisher Scientific Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing